Exploring the contribution of the AcrB homolog MdtF to drug resistance and dye efflux in a multidrug resistant E. coli isolate
Abstract: In Escherichia coli, the role of RND-type drug transporters other than the major efflux pump AcrB has largely remained undeciphered (particularly in multidrug resistant pathogens), because genetic engineering in such isolates is challenging. The present study aimed to explore the capability of the AcrB homolog MdtF to contribute to the extrusion of noxious compounds and to multidrug resistance in an E. coli clinical isolate with demonstrated expression of this efflux pump. An mdtF/acrB double-knockout was engineered, and susceptibility changes with drugs from various classes were determined in comparison to the parental strain and its acrB and tolC single-knockout mutants. The potential of MdtF to participate in the export of agents with different physicochemical properties was additionally assessed using accumulation and real-time efflux assays with several fluorescent dyes. The results show that there was limited impact to the multidrug resistant phenotype in the tested E. coli strain, while the RND-type transporter remarkably contributes to the efflux of all tested dyes. This should be considered when evaluating the efflux phenotype of clinical isolates via dye accumulation assays. Furthermore, the promiscuity of MdtF should be taken into account when developing new antibiotic agents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Antibiotics. - 10, 5 (2021) , 503, ISSN: 2079-6382
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2021
- Creator
- DOI
-
10.3390/antibiotics10050503
- URN
-
urn:nbn:de:bsz:25-freidok-2184908
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schuster, Sabine
- Vavra, Martina
- Greim, Ludwig
- Kern, Winfried V.
- Universität
Time of origin
- 2021
Other Objects (12)
Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds
Vergleich verschiedener In-Vitro-Random-Mutagenese-Methoden zur Generierung einer AcrB-Mutanten-Bibliothek als Basis für ein Screening auf Effluxpumpen-Inhibitor-Resistenz
Aufnahmeprävalenz und Parallelresistenzen 3. Generations-Cephalosporin-resistenter Enterobacteriaceae
Organization of antibiotic stewardship in Europe: the way to go
Selektionierung sowie genetische und phänotypische Charakterisierung von "Effluxpumpeninhibitor-resistenten" E. coli Mutanten aus einer AcrB-Mutantenbibliothek
Vergleichende Untersuchungen zur Empfindlichkeit von Staphylococcus aureus-Kolonisations- und Infektionsisolaten aus Bagamoyo (Tansania) und Freiburg (Deutschland) gegenüber antimikrobiellen Peptiden
Prevalence of and factors associated with antibiotic prescriptions in patients with acute lower and upper respiratory tract Infections - a case-control study
Die Eignung von Punkt-Prävalenz-Studien und der Dosisdefinitionen DDD und RDD zur Evaluation des Verbrauchs antimikrobieller Wirkstoffe am Universitätsklinikum Freiburg im Breisgau
In-person medical conferences during the COVID-19 pandemic
Proof of an outer membrane target of the efflux inhibitor Phe-Arg-[beta]-naphthylamide from random mutagenesis
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds
Vergleich verschiedener In-Vitro-Random-Mutagenese-Methoden zur Generierung einer AcrB-Mutanten-Bibliothek als Basis für ein Screening auf Effluxpumpen-Inhibitor-Resistenz
Aufnahmeprävalenz und Parallelresistenzen 3. Generations-Cephalosporin-resistenter Enterobacteriaceae
Organization of antibiotic stewardship in Europe: the way to go
Selektionierung sowie genetische und phänotypische Charakterisierung von "Effluxpumpeninhibitor-resistenten" E. coli Mutanten aus einer AcrB-Mutantenbibliothek
Vergleichende Untersuchungen zur Empfindlichkeit von Staphylococcus aureus-Kolonisations- und Infektionsisolaten aus Bagamoyo (Tansania) und Freiburg (Deutschland) gegenüber antimikrobiellen Peptiden
Prevalence of and factors associated with antibiotic prescriptions in patients with acute lower and upper respiratory tract Infections - a case-control study
Die Eignung von Punkt-Prävalenz-Studien und der Dosisdefinitionen DDD und RDD zur Evaluation des Verbrauchs antimikrobieller Wirkstoffe am Universitätsklinikum Freiburg im Breisgau
In-person medical conferences during the COVID-19 pandemic
Proof of an outer membrane target of the efflux inhibitor Phe-Arg-[beta]-naphthylamide from random mutagenesis
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds
Vergleich verschiedener In-Vitro-Random-Mutagenese-Methoden zur Generierung einer AcrB-Mutanten-Bibliothek als Basis für ein Screening auf Effluxpumpen-Inhibitor-Resistenz
Aufnahmeprävalenz und Parallelresistenzen 3. Generations-Cephalosporin-resistenter Enterobacteriaceae
Organization of antibiotic stewardship in Europe: the way to go
Selektionierung sowie genetische und phänotypische Charakterisierung von "Effluxpumpeninhibitor-resistenten" E. coli Mutanten aus einer AcrB-Mutantenbibliothek
Vergleichende Untersuchungen zur Empfindlichkeit von Staphylococcus aureus-Kolonisations- und Infektionsisolaten aus Bagamoyo (Tansania) und Freiburg (Deutschland) gegenüber antimikrobiellen Peptiden
Prevalence of and factors associated with antibiotic prescriptions in patients with acute lower and upper respiratory tract Infections - a case-control study
Die Eignung von Punkt-Prävalenz-Studien und der Dosisdefinitionen DDD und RDD zur Evaluation des Verbrauchs antimikrobieller Wirkstoffe am Universitätsklinikum Freiburg im Breisgau
In-person medical conferences during the COVID-19 pandemic
Proof of an outer membrane target of the efflux inhibitor Phe-Arg-[beta]-naphthylamide from random mutagenesis
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression